Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials

IMPORTANCE: Treatment of acquired blepharoptosis (ptosis) is currently limited to surgical intervention. OBJECTIVE: To examine the efficacy and safety of oxymetazoline hydrochloride, 0.1%, ophthalmic solution (oxymetazoline, 0.1%) in participants with acquired ptosis. DESIGN, SETTING, AND PARTICIPAN...

Descripción completa

Detalles Bibliográficos
Autores principales: Slonim, Charles B., Foster, Shane, Jaros, Mark, Kannarr, Shane R., Korenfeld, Michael S., Smyth-Medina, Robert, Wirta, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530825/
https://www.ncbi.nlm.nih.gov/pubmed/33001144
http://dx.doi.org/10.1001/jamaophthalmol.2020.3812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530825/
https://www.ncbi.nlm.nih.gov/pubmed/33001144
http://dx.doi.org/10.1001/jamaophthalmol.2020.3812

Ejemplares similares